Carrie D'Andrea
Directeur Technique/Scientifique/R&D chez ACASTI PHARMA INC.
Fortune : - $ au 30/04/2024
Postes actifs de Carrie D'Andrea
Sociétés | Poste | Début | Fin |
---|---|---|---|
ACASTI PHARMA INC. | Directeur Technique/Scientifique/R&D | 08/05/2023 | - |
Historique de carrière de Carrie D'Andrea
Anciens postes connus de Carrie D'Andrea
Sociétés | Poste | Début | Fin |
---|---|---|---|
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Corporate Officer/Principal | 01/10/2020 | 01/04/2021 |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Directeur Technique/Scientifique/R&D | 01/10/2014 | 01/03/2019 |
Formation de Carrie D'Andrea
Temple University (Pennsylvania) | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Italie | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Graduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ACASTI PHARMA INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
- Bourse
- Insiders
- Carrie D'Andrea
- Expérience